# Phase 2 Brain Injuries, Traumatic trials: 24 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 24 trials in phase 2 for Brain Injuries, Traumatic that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 Brain Injuries, Traumatic trials: 24 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/brain-injuries-traumatic

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 24
- Recruiting or not yet: 24
- Read on: November 19, 2026

## Trials

The 24 newest of 24, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 9, 2026 | NCT07867210 | Memantine Targeting Neurovascular Dysfunction After Mild and Moderate Traumatic Brain Injury (MEND) | Nova Scotia Health Authority | Phase 2 | Not yet recruiting | Traumatic Brain Injury, Mild Traumatic Brain Injury, Moderate Traumatic Brain Injury (TBI), TBI | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07867210) |
| October 1, 2026 | NCT07852728 | HBOT Effects on First Responders' Cognition and Well-Being | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder, Anxiety, Depression, Post Concussion Symptoms | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07852728) |
| September 30, 2026 | NCT07849465 | Hyperbaric Oxygen Therapy for Veterans With TBI and PCS: A Biomarker Study | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury (TBI) Patients, Post Concussive Symptoms, PTSD | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07849465) |
| July 28, 2026 | NCT07732374 | Long-Term Outcomes Following HBOT | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury, Post-Concussive Symptoms, Post-Traumatic Stress Disorder | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07732374) |
| June 4, 2026 | NCT07625995 | Feasibility and Safety of Targeting Neutral vs Liberal Fluid Balance in Traumatic Brain Injured Patients- LIMIT-TBI Trial | Erasme University Hospital | Phase 2 | Recruiting | Traumatic Brain Injury, Severe Traumatic Brain Injury, Acute Brain Injury, Neurocritical Care | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07625995) |
| January 28, 2026 | NCT07373366 | Assessment of Noninvasive Neuromodulation in a Group of Traumatic Brain Injured Patients and Healthy Volunteers | University of Sao Paulo | Phase 2 | Recruiting | Traumatic Brain Injury | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07373366) |
| December 8, 2025 | NCT07269457 | Vitamin D3 for Moderate to Mild Traumatic Brain Injury: A Randomized Trial on Inflammation and Recovery (VIMOT) | Lagos State University | Phase 2 | Recruiting | Traumatic Brain Injury (TBI) Patients, Neuroinflammation | 240 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07269457) |
| October 9, 2025 | NCT07214415 | Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy | Sponsor not shown (see the record) | Phase 2 | Recruiting | TBI Traumatic Brain Injury, PTSD - Post Traumatic Stress Disorder, Post Concussive Syndrome | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07214415) |
| August 20, 2025 | NCT07131475 | Precision Biomarkers to Detect Brain Injury in Active-Duty United States Special Operations Forces With Repeated Blast Exposure | Massachusetts General Hospital | Phase 2 | Recruiting | Blast Injury | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07131475) |
| April 16, 2025 | NCT06930261 | Dopaminergic Disruption Induced by Traumatic Coma: Dopaminergic Pathways Abnormalities and Biomarkers of Recovery Using MRI and 18F-LBT-999... | Institut National de la Santé Et de la Recherche Médicale, France | Phase 2 | Recruiting | Coma, Traumatic | 55 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06930261) |
| March 11, 2025 | NCT06870240 | A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and... | Oragenics, Inc. | Phase 2 | Not yet recruiting | Mild Traumatic Brain Injury, Concussion | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06870240) |
| November 22, 2024 | NCT06701760 | Sodium Lactate in Severe TBI | University of California, Los Angeles | Phase 2 | Not yet recruiting | Traumatic Brain Injury | 264 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06701760) |
| March 5, 2024 | NCT06293300 | Understanding and Treating Traumatic Brain Injury (TBI) Associated Photophobia With Botulinum Toxin Type A (BoNT-A) | University of Miami | Phase 2 | Recruiting | Traumatic Brain Injury | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06293300) |
| January 29, 2024 | NCT06228391 | Ketamine Treatment for PTSD and MDD in TBI | Minneapolis Veterans Affairs Medical Center | Phase 2 | Not yet recruiting | PTSD, Post Traumatic Stress Disorder, Major Depressive Disorder, Traumatic Brain Injury | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06228391) |
| November 24, 2023 | NCT06146062 | Effects of Intravascular Administration of Mesenchymal Stromal Cells Derived from Wharton's Jelly of the Umbilical Cord on Systemic... | Assistance Publique - Hôpitaux de Paris | Phase 2 | Recruiting | Traumatic Brain Injury | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06146062) |
| October 3, 2023 | NCT06065046 | Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions | Tang-Du Hospital | Phase 2 | Recruiting | Traumatic Brain Injury | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06065046) |
| July 19, 2023 | NCT05951777 | Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain Injury | Hope Biosciences LLC | Phase 2 | Recruiting | Traumatic Brain Injury | 51 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05951777) |
| March 23, 2023 | NCT05782244 | Sildenafil for Microvasculopathy in Chronic TBI | University of Pennsylvania | Phase 2 | Recruiting | Traumatic Brain Injury | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05782244) |
| January 27, 2023 | NCT05702138 | High Intensity Step Training After Traumatic Brain Injury | Craig Hospital | Phase 2 | Recruiting | Traumatic Brain Injury | 111 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05702138) |
| April 20, 2022 | NCT05337618 | Improving Neurotrauma by Depolarization Inhibition With Combination Therapy (INDICT) | University of Cincinnati | Phase 2 | Recruiting | Traumatic Brain Injury | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05337618) |
| September 16, 2020 | NCT04550377 | Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI | NYU Langone Health | Phase 2 | Recruiting | Post Traumatic Stress Disorder, Traumatic Brain Injury | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04550377) |
| October 7, 2019 | NCT04117672 | Antisecretory Factor In Severe Traumatic Brain Injury | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04117672) |
| July 1, 2019 | NCT04003285 | Allopregnanolone in Chronic Complex Traumatic Brain Injury | VA Office of Research and Development | Phase 2 | Not yet recruiting | Traumatic Brain Injury (TBI) | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04003285) |
| April 2, 2015 | NCT02407028 | Hyperbaric Oxygen Brain Injury Treatment Trial | Sponsor not shown (see the record) | Phase 2 | Recruiting | Traumatic Brain Injury | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02407028) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Erasme University Hospital | 1 |
| Nova Scotia Health Authority | 1 |
| NYU Langone Health | 1 |
| University of California, Los Angeles | 1 |
| University of Cincinnati | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| University of Pennsylvania | 1 |
| Lagos State University | 1 |
| Hope Biosciences LLC | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| University of Sao Paulo | 1 |
| VA Office of Research and Development | 1 |
| University of Miami | 1 |
| Craig Hospital | 1 |
| Oragenics, Inc. | 1 |
| Tang-Du Hospital | 1 |
| Massachusetts General Hospital | 1 |
| Minneapolis Veterans Affairs Medical Center | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 14 |
| Canada | 2 |
| France | 2 |
| Belgium | 1 |
| Italy | 1 |
| Nigeria | 1 |
| Sweden | 1 |
| Brazil | 1 |
| Australia | 1 |
| China | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Roofing contractors in the United States](https://specstream.ai/data/businesses/roofing-contractors/united-states)
- [British restaurants in the United States](https://specstream.ai/data/businesses/british-restaurants/united-states)
- [Inns in the United States](https://specstream.ai/data/businesses/inns/united-states)
- [Speech training companies in the United States](https://specstream.ai/data/businesses/speech-training-companies/united-states)
- [Chinese restaurants in the United States](https://specstream.ai/data/businesses/chinese-restaurants/united-states)
- [Leather products manufacturers in the United States](https://specstream.ai/data/businesses/leather-products-manufacturers/united-states)
